A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc. (NASDAQ: PACB) altogether on Monday, as the prices of these ETFs were up less than 1% in Monday’s session. These funds are up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 96,000 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 756,850 shares. At Monday’s closing price, this would have valued these purchases at roughly $26.6 million altogether. This is only a small fraction of the total holdings. ARKG is up roughly 59% in the past year and ARKK is up 53%.
Check out all of ARK Invest’s buys for Monday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | ETSY | Etsy | 64,213 |
| ARKG | VERV | Verve Therapeutics | 94,600 |
| ARKG | SURF | Surface Oncology | 14,000 |
| ARKG | SMFR | Sema4 | 551,578 |
| ARKG | SGFY | Signify Health | 102,356 |
| ARKG | RPTX | Repare Therapeutics | 5,897 |
| ARKG | QSI | Quantum-Si | 70,000 |
| ARKG | PACB | Pacific Biosciences of California | 96,000 |
| ARKG | FATE | Fate Therapeutics | 27,556 |
| ARKG | CMIIU | CM Life Sciences II | 5,000 |
| ARKG | EDIT | Editas Medicine | 30,356 |
| ARKG | MASS | 908 Devices | 10,671 |
| ARKK | VCYT | Veracyte | 11,405 |
| ARKK | PD | PagerDuty | 167,000 |
| ARKK | PACB | Pacific Biosciences of California | 756,850 |
| ARKK | CRSP | CRISPR Therapeutics | 55,000 |
| ARKK | BEAM | Beam Therapeutics | 81,497 |
| ARKQ | MKFG | Markforged | 18,200 |
| ARKQ | PATH | UiPath | 283,325 |
| ARKQ | SPFR | Jaws Spitfire Acquisition | 74,000 |
| ARKQ | U | Unity Software | 166,740 |
| ARKQ | LMT | Lockheed Martin | 57,202 |
| ARKQ | IRDM | Iridium Communications | 202,159 |
| ARKQ | AVAV | AeroVironment | 15,267 |
| ARKW | VUZI | Vuzix | 99,712 |
| ARKW | PD | PagerDuty | 43,000 |
| ARKW | KVSB | Khosla Venture Acquisition II | 90,000 |
| ARKW | TWLO | Twilio | 31,572 |
| ARKW | ETSY | Etsy | 61,144 |
| ARKW | CND | Concord Acquisition | 35,000 |
| ARKX | AMZN | Amazon.com | 373 |
| ARKX | LMT | Lockheed Martin | 5,784 |
| ARKX | SPFR | Jaws Spitfire Acquisition | 16,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
